“The present scenario has exposed some structural weaknesses in the EU’s medicines provide chain and also a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides claimed. She suggested that offer chain challenges be resolved in an EU pharmaceutical approach predicted to be launched by the end in the yr.The corpo